[Diagnosis and therapy of rhabdomyosarcoma in children].
An analysis of 24-month relapse-free survival in 62 patients with rhabdomyosarcoma (S.I.O.P.-89) is presented. All children with rhabdomyosarcoma (RMS) stage I have survived; stage II--90, and stage III--62%, i.e. twice as many as compared with those treated before 1993. RMS sites included retroperitoneal space, spatium perinei, urinary bladder, testicle, abdominal and thoracic cavity. Diagnosis was based on clinical, instrumental, laboratory, X-ray, radionuclide, ultrasound and morphological data. Recommendations for examination of RMS suspects were worked out for different levels of expertise.
Sharoev
T A
TA
Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
Nechushkin
M I
MI
Ivanova
N M
NM
Durnov
L A
LA
D002648:Child; D003937:Diagnosis, Differential; D006801:Humans; D009367:Neoplasm Staging; D012189:Retrospective Studies; D012208:Rhabdomyosarcoma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*